Vivienne Gomes, MD
Psychiatry · Washington, DCNPI 1134430655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 36.7% of the total. Reporting peaked in 2021 at $1,856 and has fallen 89.3% since, to $199 in 2025. Among psychiatry clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 220 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$949
- Alkermes, Inc.$711
- Neurocrine Biosciences, Inc.$210
- Johnson & Johnson$167
- plus $263 from 5 others
What the payments were for
- Food & beverage$5,85999%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 101 | $2,163 |
| AbbVie(2 entities) | 54 | $1,426 |
| Otsuka America Pharmaceutical, Inc. | 23 | $949 |
| Alkermes, Inc. | 11 | $711 |
| Neurocrine Biosciences, Inc. | 9 | $210 |
| Johnson & Johnson | 8 | $167 |
| Lundbeck LLC | 4 | $75 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,916
- VRAYLAR$488
- ARISTADA INITIO$479
- LYBALVI$464
- REXULTI$356
- ABILIFY MAINTENA$239
- ABILIFY ASIMTUFII$122
- LATUDA$112
How this compares
$5,889 in reported general payments places this provider in the 95th percentile of 226 psychiatry providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 82 | $3,440 |
| Vilazodone Hcl | 26 | $2,118 |
| Duloxetine Hcl | 39 | $951 |
| Mirtazapine | 60 | $855 |
| Benztropine Mesylate | 41 | $468 |
| Lurasidone Hcl | 23 | $413 |
| Clonazepam | 30 | $377 |
| Hydroxyzine Pamoate | 25 | $358 |
| Prazosin Hcl | 15 | $295 |
| Haloperidol | 14 | $287 |
| Fluoxetine Hcl | 41 | $285 |
| Lamotrigine | 21 | $277 |
| Sertraline Hcl | 27 | $267 |
| Quetiapine Fumarate | 19 | $260 |
| Risperidone | 13 | $230 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Washington
- Ikechi NnawuchiWashington$624K
- James GordonWashington$20K
- Thomas MellmanWashington$19K
- Tony GoreWashington$11K
- Dwight KingWashington$10K
- Igor VolkovWashington$10K
- Joel KleinmanWashington$8K
- Irfan SaeedWashington$6K
- Arda KasaciWashington$5K
- Todd AugustusWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.